<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886675</url>
  </required_header>
  <id_info>
    <org_study_id>INTERCEPT:GP</org_study_id>
    <nct_id>NCT03886675</nct_id>
  </id_info>
  <brief_title>Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection</brief_title>
  <acronym>INTERCEPT:GP</acronym>
  <official_title>Carbon-Dioxide Flushing Versus Saline Flushing in Thoracic Endovascular Aortic Repair to Reduce Neurological Injury: A Pilot Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St George's University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular brain infarction (VBI) occurs in 67% of patients undergoing TEVAR. Overt stroke
      occurs in 13% of these patients and 88% of patients suffer from neurocognitive impairment.

      Cerebral air embolisation during the stent-graft deployment phase of TEVAR may be a cause of
      VBI. Standard treatment to de-air stent-grafts is through the use of a saline flush.

      This study aims to investigate whether carbon-dioxide or saline is the better fluid to de-air
      TEVAR stent-grafts prior to insertion in to the patient and compare VBI rate in the
      carbon-dioxide group and saline group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thoracic endovascular aortic repair (TEVAR) is the re-lining of the thoracic aorta to prevent
      life threatening haemorrhage and death from rupture. This involves a small cut in the femoral
      artery in the groin and under imaging guidance, the insertion of wires and a stent into the
      thoracic aorta.

      Prior to insertion into the patient, stents are flushed with saline to remove air and prevent
      air reaching the brain that can cause a form of brain injury known as vascular brain
      infarction (VBI). However, our preliminary clinical data suggests that saline flushing is not
      effective at de-airing stent-grafts used in TEVAR.

      Carbon-dioxide has been used extensively in cardiac surgery to displace air from the chest
      cavity to prevent peri-procedural cerebral air embolisation. We hypothesise that flushing the
      stent-grafts with carbon-dioxide may be better at removing air from the stent-grafts than
      saline flush.

      Patients undergoing TEVAR will be approached to participate in this study. After written
      consent is obtained, participants will be randomised to undergo (TEVAR) with carbon dioxide
      or saline flushing of stent-grafts. Pre-operatively, participants will undergo a
      diffusion-weighted MRI brain scan, full neurological examination and neurocognitive testing.
      Intra-operatively, participants will undergo continuous transcranial doppler monitoring (TCD)
      of the middle cerebral artery (MCA) to look for cerebral air embolisation at stent-graft
      deployment phase of TEVAR. Post-operatively, particpants will undergo another
      diffusion-weighted brain MRI within 72 hours post-procedure, neurological examination for the
      first 7 days, and neurocognitive tests prior to discharge, and at 6-weeks and 6-month
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomisation</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will be blinded to treatment allocation. Assessment of TCD embolic data, DW-MRI scan reporting and neurological and neurocognitive assessment will be carried out by blinded trained assessors.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with new diffusion-weighted MRI brain scan</measure>
    <time_frame>Within 72hrs</time_frame>
    <description>As above</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number, size and location of new ischaemic lesions on post-operative diffusion-weighted MRI scans</measure>
    <time_frame>Within 72hrs</time_frame>
    <description>As above</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of gaseous and solid intra-operative transcranial doppler microembolic signals by phase of TEVAR</measure>
    <time_frame>Duration of surgery</time_frame>
    <description>As above</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke rate</measure>
    <time_frame>1-7 days within hospital, 6-weeks post-operatively and 6-months post-operatively.</time_frame>
    <description>Number of neurological events up to 7 days in hospital, and at 6-week and 6-months follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with neurocognitive impairment from baseline</measure>
    <time_frame>3-7 days post-operatively, 6-weeks post-operatively and 6-months post-operatively.</time_frame>
    <description>Comparison of pre-operative and post-operative neurocognitive tests at discharge, and at 6-weeks and 6-months follow-up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Stroke</condition>
  <condition>Silent Cerebral Infarction</condition>
  <condition>Neurocognitive Dysfunction</condition>
  <condition>Vascular Brain Injury</condition>
  <arm_group>
    <arm_group_label>carbon-dioxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Flushing of stent-grafts in TEVAR with carbon-dioxide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flushing of stent-grafts with saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CO2 flushing</intervention_name>
    <description>As above</description>
    <arm_group_label>carbon-dioxide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline flushing</intervention_name>
    <description>As above</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All participants suitable for TEVAR with capacity to consent

        Exclusion Criteria:

          -  Participants who lack capacity to consent

          -  Contraindications to MRI such as pacemaker

          -  Pregnant participants

          -  Participants who do not wish to participate

          -  Participants &lt;18yrs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Gibbs</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lydia Hanna</last_name>
    <phone>07747002704</phone>
    <email>l.hanna@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Gibbs</last_name>
    <email>r.gibbs@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Imperial College London</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Ruth Nicholson</last_name>
      <email>r.nicholson@imperial.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Perera AH, Rudarakanchana N, Monzon L, Bicknell CD, Modarai B, Kirmi O, Athanasiou T, Hamady M, Gibbs RG. Cerebral embolization, silent cerebral infarction and neurocognitive decline after thoracic endovascular aortic repair. Br J Surg. 2018 Mar;105(4):366-378. doi: 10.1002/bjs.10718. Epub 2018 Feb 12.</citation>
    <PMID>29431856</PMID>
  </reference>
  <reference>
    <citation>Kahlert P, Eggebrecht H, Jánosi RA, Hildebrandt HA, Plicht B, Tsagakis K, Moenninghoff C, Nensa F, Mummel P, Heusch G, Jakob HG, Forsting M, Erbel R, Schlamann M. Silent cerebral ischemia after thoracic endovascular aortic repair: a neuroimaging study. Ann Thorac Surg. 2014 Jul;98(1):53-8. doi: 10.1016/j.athoracsur.2014.03.037. Epub 2014 May 17.</citation>
    <PMID>24841546</PMID>
  </reference>
  <reference>
    <citation>Masada K, Kuratani T, Shimamura K, Kin K, Shijo T, Goto T, Sawa Y. Silent cerebral infarction after thoracic endovascular aortic repair: a magnetic resonance imaging study. Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1071-1078. doi: 10.1093/ejcts/ezy449.</citation>
    <PMID>30629169</PMID>
  </reference>
  <reference>
    <citation>Inci K, Koutouzi G, Chernoray V, Jeppsson A, Nilsson H, Falkenberg M. Air bubbles are released by thoracic endograft deployment: An in vitro experimental study. SAGE Open Med. 2016 Dec 7;4:2050312116682130. eCollection 2016.</citation>
    <PMID>27994872</PMID>
  </reference>
  <reference>
    <citation>Rohlffs F, Tsilimparis N, Saleptsis V, Diener H, Debus ES, Kölbel T. Air Embolism During TEVAR: Carbon Dioxide Flushing Decreases the Amount of Gas Released from Thoracic Stent-Grafts During Deployment. J Endovasc Ther. 2017 Feb;24(1):84-88. doi: 10.1177/1526602816675621. Epub 2016 Oct 26.</citation>
    <PMID>27798380</PMID>
  </reference>
  <reference>
    <citation>Martens S, Neumann K, Sodemann C, Deschka H, Wimmer-Greinecker G, Moritz A. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery. Ann Thorac Surg. 2008 Feb;85(2):543-7. doi: 10.1016/j.athoracsur.2007.08.047.</citation>
    <PMID>18222261</PMID>
  </reference>
  <reference>
    <citation>Ganguly G, Dixit V, Patrikar S, Venkatraman R, Gorthi SP, Tiwari N. Carbon dioxide insufflation and neurocognitive outcome of open heart surgery. Asian Cardiovasc Thorac Ann. 2015 Sep;23(7):774-80. doi: 10.1177/0218492315583562. Epub 2015 May 4.</citation>
    <PMID>25939908</PMID>
  </reference>
  <reference>
    <citation>Bismuth J, Garami Z, Anaya-Ayala JE, Naoum JJ, El Sayed HF, Peden EK, Lumsden AB, Davies MG. Transcranial Doppler findings during thoracic endovascular aortic repair. J Vasc Surg. 2011 Aug;54(2):364-9. doi: 10.1016/j.jvs.2010.12.063. Epub 2011 Mar 3.</citation>
    <PMID>21371850</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Silent cerebral infarction</keyword>
  <keyword>Carbon dioxide</keyword>
  <keyword>Thoracic endovascular aortic repair</keyword>
  <keyword>TEVAR</keyword>
  <keyword>DW-MRI</keyword>
  <keyword>Vascular brain infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Cerebrovascular Trauma</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

